Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
This is the most important earnings week of the October season. Tesla reports Q3 results on 21 October. General Motors posts Q3 on 20 October. Netflix and Intuitive Surgical both report Tuesday after the close. Lam Research and Procter & Gamble follow later in the week.
ORTEX Alt Data is pointing firmly higher for both auto names ahead of their prints. German car registrations, a leading indicator for Tesla revenue with a 43-day lag, are running 269% above the same quarter last year across three consecutive months. For GM, the same dataset leads revenue by 15 days and is running 133% above the year-ago period. Both readings are the strongest in their respective histories for the current quarter.
Options bears are concentrated in semiconductors. NVDA and MU top the bearish flow rankings by dollar value, with put positioning outweighing calls over the past seven days. Tesla options show a split picture, with heavy flow on both sides ahead of Tuesday's print.
Short sellers made their clearest move in retail. Chewy saw its short interest jump 25 percentage points in a week to 91.3% of free float. Wolfspeed remains the most entrenched bear position at 83.8% SI of free float with over 10 days to cover.
The MSCI World November review rank date falls on 19 October. Fabrinet saw its deletion probability jump from 8% to 49% overnight. A bad Monday session could close much of the 9.3% gap to the exit line. Forced MSCI World selling would total $826M if the deletion is confirmed on 11 November. Elsewhere, Xero carries a 73% probability of MSCI World deletion with $393M of forced selling behind it.
EU HICP inflation rose to 3.8% in September 2026, the highest September reading in two years. Analyst desks are divided on US regional banks. PNC and US Bancorp each drew opposing target changes from Oppenheimer and RBC Capital, reflecting uncertainty about near-term earnings pressure ahead of their results.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.